stockrowCorcept Therapeutics Incorporated
CORT Healthcare Biotechnology
Corcept Therapeutics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $761.4 million, up 12.8% from fiscal 2024.
- Revenue
- +64.0%
- EPS
- +525.8%
- Free cash flow
- +161.0%
Quarter to September 2026, against a year earlier
Follow CORT
Alert me
Corcept Therapeutics Incorporated (CORT) Operating margin
Corcept Therapeutics Incorporated's operating margin over the twelve months to 30 September 2026 was 11.5%, up 5.6 percentage points from fiscal 2025 (5.88%). Over the past ten years it has ranged from −6.85% (fiscal 2015) to 36.4% (fiscal 2019); the current reading is higher than 18% of that period. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 5.88% | (14.41) |
| FY2024 | 20.3% | (1.95) |
| FY2023 | 22.2% | (5.79) |
| FY2022 | 28.0% | (5.98) |
| FY2021 | 34.0% | (2.22) |
| FY2020 | 36.2% | (0.18) |
| FY2019 | 36.4% | 0.79 |
| FY2018 | 35.6% | 2.42 |
| FY2017 | 33.2% | 20.68 |
| FY2016 | 12.5% | 19.37 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 33.7% | 17.58 |
| Jun 2026 | 16.1% | 46.20 |
| Mar 2026 | −30.1% | (32.30) |
| Dec 2025 | 2.22% | (2.70) |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| KRYS Krystal Biotech, Inc. compare | 48.4% |
| PTGX Protagonist Therapeutics, Inc. compare | 20.7% |
| CORT Corcept Therapeutics Incorporated | 11.5% |
| PRAX Praxis Precision Medicines, Inc. compare | 0.00% |
| ABVX Abivax SA Sponsored ADR compare | 0.00% |
| SYRE Spyre Therapeutics, Inc. compare | 0.00% |
| MDGL Madrigal Pharmaceuticals, Inc. compare | −10.7% |
| ARWR Arrowhead Pharmaceuticals, Inc. compare | −33.8% |
| CYTK Cytokinetics, Incorporated compare | −625.2% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on CORT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement